SCHEMBL27495397

SCHEMBL27495397

CC(C)(Cc1ccc(O)cc1)OC(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 1/20 0.54
ESR1 P03372 5/20 0.52
CYP3A4 P08684 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
NFKB1 P19838 1/20 0.49
CYP2C19 P33261 1/20 0.49
LMNA P02545 1/20 0.48
PMP22 Q01453 1/20 0.48
NLRP3 Q96P20 1/20 0.48
ESR2 Q92731 4/20 0.47
CA2 P00918 2/20 0.46
IDO1 P14902 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.39
CAMK2A Q9UQM7 1/20 0.38
ABAT P80404 1/20 0.38
SLC7A5 Q01650 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27495164 0.87 CYP3A4 (0.50) BLMESR1CYP3A4CYP1A2CYP2D6
SCHEMBL28272596 0.86 CYP3A4 (0.49) BLMCYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL27586112 0.86 CYP3A4 (0.49) BLMCYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL27734453 0.86 CYP3A4 (0.49) BLMESR1CYP3A4CYP1A2CYP2D6
SCHEMBL27915722 0.86 CYP3A4 (0.49) BLMCYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL2491151 0.84 CYP3A4 (0.48) BLMCYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL27484098 0.84 CYP2C19 (0.68) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1
SCHEMBL27495398 0.84 CYP3A4 (0.48) BLMESR1CYP3A4CYP1A2CYP2D6
SCHEMBL27926127 0.84 CYP3A4 (0.48) BLMCYP3A4CYP1A2CYP2D6CYP2C9
SCHEMBL3656311 0.84 SMN1; SMN2 (0.48) CYP3A4CYP1A2CYP2D6CYP2C9NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103242192-B The inhibitor of 11-beta-hydroxysteroid dehydrogenase 1 type enzyme ABBVIE INC. (US) 2016-05-04 CN disclosed
CN-105408312-A Quinoline derivatives ONO PHARMACEUTICAL CO 2016-03-16 CN disclosed
CN-105026387-A Pyridine derivatives as soft rock inhibitors AMAKEM NV 2015-11-04 CN disclosed
CN-102741240-B Pyrimidine compounds as delta opioid receptor modulators JANSSEN PHARMACEUTICA NV 2015-05-06 CN disclosed
CN-101541783-B pyridinonyl PDK1 inhibitors SUNESIS PHARMACEUTICALS, INC. (US) 2014-10-01 CN disclosed
CN-103242192-A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme ABBVIE INC 2013-08-14 CN disclosed
CN-102741240-A Pyrimidine compounds as delta opioid receptor modulators JANSSEN PHARMACEUTICA NV 2012-10-17 CN disclosed
CN-101720319-A Thiazolidine derivatives and methods for the preparation thereof KAINOS MEDICINE INC 2010-06-02 CN disclosed
CN-101679261-A Piperazine and piperidine mglur5 potentiators ASTRAZENECA AB 2010-03-24 CN disclosed
CN-100562319-C 2-cyanopyrrole and pyrimidine and its pharmaceutical use NOVARTIS AG (CH) 2009-11-25 CN disclosed
CN-101541783-A Pyridinonyl PDK1 inhibitors SUNESIS PHARMACEUTICALS (US) 2009-09-23 CN disclosed
CN-101443334-A Anti-viral compounds ABBOTT LAB (US) 2009-05-27 CN disclosed
CN-101384591-A Antiviral compounds ABBOTT LAB (US) 2009-03-11 CN disclosed
CN-100402510-C Oxazole derivatives and their use as insulin sensitizers HOFFMANN LA ROCHE (CH) 2008-07-16 CN disclosed
CN-101137616-A Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 enzyme ABBOTT LAB (US) 2008-03-05 CN disclosed
CN-1809541-A Aniline derivatives HOFFMANN LA ROCHE (CH) 2006-07-26 CN disclosed
CN-1756553-A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof NOVARTIS AG (CH) 2006-04-05 CN disclosed
CN-1668606-A Oxazole derivatives and their use as insulin sensitizers HOFFMANN LA ROCHE (CH) 2005-09-14 CN disclosed
CN-1208329-C Novel aniline derivative HOFFMANN LA ROCHE (CH) 2005-06-29 CN disclosed
CN-1443179-A Aniline derivatives HOFFMANN LA ROCHE (CH) 2003-09-17 CN disclosed